Immediate Impact
20 standout
Citing Papers
Breast cancer: A review of risk factors and diagnosis
2024 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
Works of Anna Morra being referenced
Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
2020
MA 19.02 Tremelimumab plus Durvalumab in First- or Second-Line Mesothelioma Patients: Final Analysis of the NIBIT-MESO-1 Study
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Anna Morra | 16 | 31 | 5 | 22 | 20 | 10 | 85 | |
| Hana Zahed | 9 | 37 | 3 | 23 | 14 | 10 | 68 | |
| Ángela Santonja | 8 | 31 | 7 | 42 | 36 | 10 | 94 | |
| Leslie E. Oldfield | 11 | 47 | 9 | 37 | 33 | 13 | 104 | |
| Arkom Chaiwerawattana | 9 | 59 | 3 | 20 | 26 | 7 | 112 | |
| Guillermo Yanowsky Reyes | 5 | 45 | 36 | 21 | 9 | 9 | 86 | |
| Guanhua Yu | 23 | 57 | 16 | 20 | 45 | 8 | 106 | |
| Axel Gräwingholt | 17 | 52 | 1 | 16 | 6 | 8 | 87 | |
| Gopal Krishna Dhondalay | 16 | 16 | 17 | 17 | 91 | 11 | 191 | |
| Somchai Thanasitthichai | 5 | 36 | 8 | 15 | 14 | 10 | 101 | |
| Tara E. Soumerai | 6 | 31 | 5 | 16 | 28 | 11 | 67 |
All Works
Login with ORCID to disown or claim papers
Loading papers...